Huangshi Group (002329.SZ): Net profit of 5.164,500 yuan in the first quarter increased 5.84% year-on-year
Gelonghui, April 29 | Huangshi Group (002329.SZ) released its report for the first quarter of 2024. Operating income for the reporting period was 479.6 million yuan, down 41.78% year on year; net profit attributable to shareholders of listed companies was 5.164,500 yuan, up 5.84% year on year; net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss - 6.5426 million yuan; basic earnings per share.
Chongqing Beer (600132.SH)'s net profit of 452 million yuan in the first quarter increased 16.78% year-on-year
Gelonghui, April 29丨Chongqing Beer (600132.SH) released its report for the first quarter of 2024. During the reporting period, the company achieved sales of 886,800 kiloliters of beer, an increase of 5.25% over the same period of the previous year; achieved operating income of 4.293 billion yuan, an increase of 7.16% over 4.06 billion yuan in the same period last year; achieved net profit attributable to shareholders of listed companies of the company, an increase of 16.78% over 387 million yuan in the same period last year; achieved net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss of 446 million yuan. 381 million compared to the same period last year
RheinBio (002166.SZ): The overall gross margin for the whole year is expected to remain within a relatively reasonable margin of 25-30%
Gelonghui, April 29丨RheinBio (002166.SZ) held an online exchange on April 26, 2024 to discuss “Based on the first quarter results, does the company have performance guidelines for the full year 2024?” The company replied that in terms of revenue, we will continue to maintain a 15% -20 growth forecast after considering possible quarterly performance fluctuations. In terms of profit, judging by the gross margin level in the first quarter and the price trend of raw materials this year, the overall gross margin for the whole year is expected to remain within a relatively reasonable margin range of 25-30%.
Rheinbio (002166.SZ): Currently, the construction of the synthetic biology plant has entered a relatively advanced stage, and it is expected to be put into use in the third quarter
Gelonghui April 29 丨 Rheinland Biotech (002166.SZ) held an online exchange on April 26, 2024, about “What are the company's latest developments in the synthetic biology business?” The company replied that the construction of the synthetic biology plant has now entered a relatively advanced stage and is expected to be put into use in the third quarter. In terms of research and development, R&D projects for full synthesis and enzymatic transformation technology are progressing normally, and phased results have been achieved. In particular, projects to produce some high-value natural sweetener ingredients through enzymatic conversion technology have passed pilot tests, and can be quickly put into production after the factory is completed.
Pinwo Foods (300892.SZ) announced first-quarter results, with a net loss of 4.4936 million yuan, a year-on-year decrease of 79.32%
Pinwo Foods (300892.SZ) released its report for the first quarter of 2024. During the reporting period, the company achieved operating income of 2...
RheinBio (002166.SZ): Net profit of 267.901 million yuan in the first quarter increased by 34.37% year-on-year
Gelonghui, April 26 | Rhine Biotech (002166.SZ) released its report for the first quarter of 2024. Operating revenue for the reporting period was 341 million yuan, up 35.07% year on year; net profit attributable to shareholders of listed companies was 267.91 million yuan, up 34.37% year on year; net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss was 395.709 million yuan, up 372.05% year on year; basic earnings per share were 0.04 yuan.